Prevention of heart failure progression: current approaches

被引:0
|
作者
Lechat, P [1 ]
机构
[1] Pitie Salpetriere Hosp, Dept Pharmacol, F-7513 Paris, France
关键词
heart failure; compensatory mechanisms; sympathetic nervous system; renin-angiotensin-aldosterone system; diuretics; ACE inhibitors; alpha- and beta-adrenergic blockers;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure results from damage and stress to the myocardium whatever the aetiology. An increase in stress by cardiac overload is initially overcome by compensatory mechanisms that maintain blood pressure through a combination of the sympathetic nervous system and the renin-angiotensin-aldosterone system. These mechanisms may also alter myocyte function and induce progressive cell death and replacement by fibrous tissue. Disease therapy must reduce cardiac loading and avoid blood pressure control by mechanisms that have deleterious effects. Therapy includes diuretics, vasodilators and alpha-and beta-adrenergic blockade. Complete blockade of all receptors involved in the adverse effects of neurohormonal stimulation might represent an ultimate therapy objective, and improve subsequent prognosis. Large clinical trials are in progress to determine the therapy of choice in the prevention of progression of heart failure.
引用
收藏
页码:B12 / B18
页数:7
相关论文
共 50 条
  • [11] Prevention and reversal of the progression of hypertrophy and heart failure in the ageing SHR
    Brown, L
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (11) : A13 - A13
  • [12] Novel drugs and current therapeutic approaches in the treatment of heart failure
    Bonarjee, VVS
    Dickstein, K
    DRUGS, 1996, 51 (03) : 347 - 358
  • [13] Current and newer approaches in the drug treatment of congestive heart failure
    vanZwieten, PA
    CARDIOVASCULAR DRUGS AND THERAPY, 1997, 10 (06) : 693 - 702
  • [14] Current approaches to preventing heart failure readmissions and decompensated disease
    Mace, Matthew
    Lidstromer, Niklas
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024, 72 (05) : 535 - 543
  • [15] Current and newer approaches in the drug treatment of congestive heart failure
    P. A. van Zwieten
    Cardiovascular Drugs and Therapy, 1997, 10 : 693 - 702
  • [16] Current Approaches to Worsening Heart Failure: Pathophysiological and Molecular Insights
    D'Amato, Andrea
    Prosperi, Silvia
    Severino, Paolo
    Myftari, Vincenzo
    Francia, Aurora Labbro
    Cestie, Claudia
    Pierucci, Nicola
    Marek-Iannucci, Stefanie
    Mariani, Marco Valerio
    Germano, Rosanna
    Fanisio, Francesca
    Lavalle, Carlo
    Maestrini, Viviana
    Badagliacca, Roberto
    Mancone, Massimo
    Fedele, Francesco
    Vizza, Carmine Dario
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [17] Consensus statement on the current pharmacological prevention and management of heart failure
    Sindone, Andrew P.
    De Pasquale, Carmine
    Amerena, John
    Burdeniuk, Christine
    Chan, Alicia
    Coats, Andrew
    Hare, David L.
    Macdonald, Peter
    Sverdlov, Aaron
    Atherton, John J.
    MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (04) : 212 - 217
  • [18] Atrial fibrillation and heart failure: A contemporary review of current management approaches
    Lee, Justin Z.
    Cha, Yong-Mei
    HEART RHYTHM O2, 2021, 2 (06): : 762 - 770
  • [19] Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
    Shchendrygina, A. A.
    Zhbanov, K. A.
    Privalova, E., V
    Yusupova, A. O.
    Danilogorskaya, Yu A.
    Salakheeva, E. Yu
    Sokolova, I. Ya
    Tsatsurova, S. A.
    Ageeva, A. A.
    Belenkov, Yu N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (03) : 476 - 483
  • [20] PROGRESSION OF CHRONIC HEART FAILURE: PROGNOSTIC CRITERIA AND NON-DRUG PREVENTION
    Kurlyanskaya, E. R.
    Denisevich, T. L.
    Mrochek, A. G.
    KARDIOLOGIYA, 2019, 59 (04) : 26 - 32